| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |